6C9J
AMP-activated protein kinase bound to pharmacological activator R734
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-D |
Synchrotron site | APS |
Beamline | 21-ID-D |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-11-11 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 1.0 |
Spacegroup name | P 61 2 2 |
Unit cell lengths | 123.296, 123.296, 404.921 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 49.646 - 3.050 |
R-factor | 0.2151 |
Rwork | 0.214 |
R-free | 0.22460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4rer |
RMSD bond length | 0.004 |
RMSD bond angle | 0.782 |
Data reduction software | iMOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 3.220 |
High resolution limit [Å] | 3.050 | 3.050 |
Rmerge | 0.807 | 0.090 |
Number of reflections | 32841 | |
<I/σ(I)> | 10 | |
Completeness [%] | 91.1 | |
Redundancy | 34.4 | |
CC(1/2) | 0.997 | 0.722 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | 0.1 M tri-ammonium citrate pH7, 12% w/v PEG 3350 |